Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for perioperative myocardial protection in coronary heart disease patients undergoing non-cardiac surgery
ChiCTR-TRC-14004266Phase 4Completed
- Sponsor
- Department of Anesthesiology, Second Affiliated Hospital of Zhejiang Chinese Medical University
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in coronary arteriosclerosis (2 arms), sponsored by Department of Anesthesiology, Second Affiliated Hospital of Zhejiang Chinese Medical University. Primary endpoint: Interleukin-6. Started Mar 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-14004266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004266.